References
- Lejeune J, Maunoury C, Prieur M, et al. Translocation sauteuse (5p;15q), (8q;15q), t(12q;15q). Ann Genet 1979;22:210–213.
- Berger R, Bernard OA. Jumping translocations. Genes Chrom Cancer 2007;46:717–723.
- Manola KN, Georgakakos VN, Stavropoulou C, et al. Jumping translocations in hematological malignancies: a cytogenetic study of five cases. Cancer Genet Cytogenet 2008;187:85–94.
- Lizcova L, Zemanova Z, Malinova E, et al. Jumping translocations in bone marrow cells of pediatric patients with hematologic malignancies: a rare cytogenetic phenomenon. Cancer Genet 2011;204:348–349.
- Padilla-Nash HM, Heselmeyer-Haddad K, Wangsa D, et al. Jumping translocations are common in solid tumor cell lines and result in recurrent fusions of whole chromosome arms. Genes Chrom Cancer 2001;30:349–363.
- Jamet D, Marzin Y, Douet-Guilbert N, et al. Jumping translocations in multiple myeloma. Cancer Genet Cytogenet 2005;161:159–163.
- Najfeld V, Tripodi J, Scalise A, et al. Jumping translocations of the long arms of chromosome 1 in myeloid malignancies is associated with a high risk of transformation to acute myeloid leukaemia. Br J Haematol 2010;151:288–291.
- Petkovic I, Konja J, Dominis M, et al. Jumping translocations involving 11q in a non-Hodgkin lymphoma. Cancer Genet Cytogenet 1999;114:121–125.
- Kakazu N, Kito K, Hitomi T, et al. Characterization of complex chromosomal abnormalities in B-cell lymphoma by a combined sperctral karyotyping (SKY) analysis and fluorescence in situ hybridization -FISH) using a 14q telomere probe. Am J Hematol 2000;65:291–297.
- Puiggros A, Blanco G, Espinet B. Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go. Biomed Res Int 2014;2014:435983.
- Hruba M, Dvorak P, Weberova L, et al. Independent coexistence of clones with 13q14 deletion at reciprocal translocation breakpoint and 13q14 interstitial deletion in chronic lymphocytic leukemia. Leuk Lymphoma 2012;53:2054–2062.
- Puiggros A, Venturas M, Salido M, et al. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome. Genes Chrom Cancer 2014;53:788–797.
- De Braekeleer E, Douet-Guilbert N, Basinko A, et al. Using bacterial artificial chromosomes in leukemia research: the experience at the university cytogenetics laboratory in Brest, France. J Biomed Biotechnol 2011;2011:329471.
- Fitchett M, Griffiths MJ, Oscier DG, et al. Chromosome abnormalities involving band 13q14 in hematologic malignancies. Cancer Genet Cytogenet 1987;24:143–150.
- Peterson LC, Lindquist LL, Church S, .Frequent clonal abnormalities of chromosome band 13q14 in B-cell chronic lymphocytic leukemia: multiple clones, subclones, and nonclonal alterations in 82 midwestern patients. Genes Chrom Cancer 1992;4:273–280.
- Fegan C, Robinson H, Thompson P, et al. Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease. Leukemia 1995;9:2003–2008.
- Gardiner AC, Corcoran MM, Oscier DG. Cytogenetic, fluorescence in situ hybridisation, and clinical evaluation of translocations with concomitant deletion at 13q14 in chronic lymphocytic leukaemia. Genes Chrom Cancer 1997;20:73–81.
- Antosz H, Kitlinska J, Kwiatkowska-Drabik B, et al. Rb1 gene expression in B-cell lymphocytic leukaemia cases with deletion in the 13q14 region. Cytobios 1997;92:111–121.
- Mayr C, Speicher MR, Kofler DM, et al. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood 2006;107:742–751.
- Adeyinka A, Wei S, Sanchez J. Loss of 17p is a major consequence of whole-arm chromosome translocations in hematologic malignancies. Cancer Genet Cytogenet 2007;173:136–143.
- Wren C, Moriarty H, Marsden K, et al. Cytogenetic investigations of chronic lymphocytic leukemia. Cancer Genet Cytogenet 2010; 198:155–161.
- Andreasson P, Hoglund M, Jonson T, et al. Molecular characterization of jumping translocations reveals spatial and temporal breakpoint heterogeneity. Leukemia 1998;12:1411–1416.